| 000 | 01097 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515111647.0 | ||
| 264 | 0 | _c20080327 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1748-1716 | ||
| 024 | 7 |
_a10.1111/j.1748-1716.2007.01823_1.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStengl, Milan | |
| 245 | 0 | 0 |
_aWhat is more dangerous in long QT 3 syndrome? Arrhythmogenic trigger or substrate? _h[electronic resource] |
| 260 |
_bActa physiologica (Oxford, England) _cApr 2008 |
||
| 300 |
_a453 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCardiac Electrophysiology |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
| 650 | 0 | 4 |
_aTachycardia, Ventricular _xprevention & control |
| 773 | 0 |
_tActa physiologica (Oxford, England) _gvol. 192 _gno. 4 _gp. 453 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1748-1716.2007.01823_1.x _zAvailable from publisher's website |
| 999 |
_c17810696 _d17810696 |
||